The road remains challenging, with many barriers to approval. Despite the barriers, investment continues to flow, with the hope that a novel cell therapy will break the barriers and pave the way for new treatment options for patients. Our expert panel from across the industry will discuss the roadblocks to getting approvals for solid tumor cell therapies and what are the strategies that developers are utilising to overcome these obstacles.

• Insight on the trends emerging from landscape and what cutting edge innovation technology is spurring the growing investment into solid tumor cell therapy research.
• A comprehensive overview of the competitive solid tumor cell therapy landscape acknowledging the key players leading the field.
• Practical considerations from leading industry experts on navigating cell therapy development for solid tumors.
• A picture of what we can likely expect ahead based on recent approvals and late stage activity.
• Your prime opportunity to seek answers to all your drug development questions during the webinar.